Among the targeted genes, we also identified three mutations in FBN1 and TSC1 gene in PSP patients in addition to FLCN gene, but no predicted harmful variant was detected in TSC2, CBS, COL3A1 and SERPINA1 gene. This evidence concerns the gene FLCN and supranuclear palsy, progressive, 1.